Details

Last Funding Type

Grant

Last Funding Money Raised

€17.50M

Industries

Health Care,Laser,Medical Device

Founded date

Mar 21, 2013

Number Of Employee

11 - 50

Operating Status

Active

BELKIN Vision is developing an automated, fast glaucoma laser treatment, aimed at revolutionizing accessibility to glaucoma care by becoming the first-line choice for glaucoma therapy for every patient, all over the world.
BELKIN Vision is addressing the growing disparity between the enormous number of glaucoma patients (67M) and the limited number of ophthalmologists (212,000), by enabling the doctor to treat many more patients quickly.
BELKIN’s innovative technology is applicable for the prevalent Open Angle Glaucoma (OAG, 70% of total glaucoma patients) and it will pioneer laser treatment for Angle Closure Glaucoma (ACG, 30%), which is most common among Asian populations.
• The innovative solution provides treatment that is patient friendly - non-invasive, non-contact, instantaneous & painless.
• BELKIN Laser has the opportunity to completely transform the conventional glaucoma treatment from a specialized procedure performed mainly by glaucoma specialists, into a treatment that is effective, safe and reliable which can be carried out by all ophthalmologists and other healthcare providers.